ITH Pharma specialises in the provision of of aseptic compounding services for all therapy areas - particularly Parenteral Nutrition, Chemotherapy and CIVAS.

The company was launched in October 2008 by the founding members of Intra-Tech Healthcare, so although we're new, we are experienced and have the understanding of what you require from a supplier.

Our team leads the industry in innovation, providing flexible, cost effective services with both batch and bespoke items for adults, paediatrics and neonates.

London, GB
Size (employees)
91 (est)+8%
ITH Pharma was founded in 2008 and is headquartered in London, GB
Report incorrect company information

Key People/Management at ITH Pharma

Karen Hamling

Karen Hamling

Managing Director
Adam Bloom

Adam Bloom

Executive Director
Andrew Winstanley

Andrew Winstanley

Commercial Director
Richard Bateman

Richard Bateman

Director of Quality
Shesh Ashsarya

Shesh Ashsarya

Finance Manager

ITH Pharma Office Locations

ITH Pharma has offices in Greater London and London
Greater London, GB (HQ)
10 7 Premier Park Rd
London, GB (HQ)
Premier Park Rd
Show all (2)
Report incorrect company information

ITH Pharma Financials and Metrics

Summary Metrics

Founding Date


ITH Pharma Financials

ITH Pharma's revenue was reported to be £38.58 m in FY, 2017

Revenue (FY, 2017)

38.6 m

Gross profit (FY, 2017)

11.1 m

Gross profit margin (FY, 2017), %


Net income (FY, 2017)

1.7 m

EBITDA (FY, 2017)

2.7 m

EBIT (FY, 2017)

2.3 m

Cash (31-Mar-2017)

9.1 k
GBPFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017


8.2 m12.1 m15.1 m20.4 m26.2 m30.8 m38.6 m

Revenue growth, %


Cost of goods sold

10 m13.6 m18.7 m22.1 m27.5 m

Gross profit

5.1 m6.8 m7.5 m8.6 m11.1 m
GBPFY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017


18.5 k314.4 k38.4 k33.1 k17 k9.1 k

Accounts Receivable

798.9 k1.2 m1.3 m1.2 m2 m3 m3.5 m4.3 m6.1 m


252.7 k315.6 k587.5 k766.1 k1.2 m1.4 m1.4 m1.6 m3 m

Current Assets

1.1 m1.5 m2.4 m2.4 m3.8 m4.8 m5.4 m6.2 m9.6 m
GBPFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

34.1 k335 k547.1 k947.3 k282.2 k494.6 k1.7 m

Cash From Operating Activities

(198.5 k)412.8 k148.6 k605.7 k799.8 k276.4 k(489.4 k)

Cash From Financing Activities

262.9 k(160.2 k)(305.9 k)(1.1 m)29.8 k

Net Change in Cash

(118 k)88.9 k(101.8 k)(744.2 k)447.4 k(739.7 k)(1.8 m)
GBPY, 2017


723.9 k

Financial Leverage

3.6 x
Show all financial metrics
Report incorrect company information